Celldex Therapeutics | CLDX - Capitale Ordinario





Capitale Ordinario Cambiamento Data
AbbVie USD 1.77B 1.75B 2025-06
Agenus USD 38.52M 3.2M 2026-03
Amgen USD 541M 1000K 2026-06
Bristol-Myers Squibb USD 2.04B 1.74B 2025-09
Celldex Therapeutics USD 78.5M 11.93M 2026-06
Glaxosmithkline GBP 4.05B 20.6M 2026-03
Nektar Therapeutics USD 29.47M 9.09M 2026-03
Northwest Biotherapeutics USD 1.61B 88.6M 2026-03
Pfizer USD 5.7B 0 2026-06
Rigel Pharmaceuticals USD 17K 158K 2024-06
Roche Holding CHF 796.77M 1.15M 2026-06